Patients with kidney disease are at risk to develop acute kidney injury following administration of iodinated contrast. Depending on the estimated glomerular filtration rate (eGFR) and the presence of additional risk factors, preventive measures prior to iodinated contrast agent exposure may be indicated. In general, contrast-induced acute kidney injury (CI-AKI) is defined as a rise in serum creatinine of ≥0.5mg/dl (≥44μmol/l) or a 25% increase from baseline value, assessed at 48h after a contrast-enhanced radiological procedure [1,2].